October 2025, at one of the most important conferences in European oncology—the “European Society for Medical Oncology Annual Meeting”—China delivered an impressive performance: 35 studies were selected for oral presentations, and three advanced to the highest-level“Presidential Sessions”.

China’s biomedical sector is undergoing a profound transformation.